[Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D013805:Theobromine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D004338:Drug Combinations; D009539:Nicotinic Acids; D014665:Vasodilator Agents; C007138:nicotinic acid, pentifylline drug combination; D004088:Dihydroergotoxine; D013805:Theobromine
Therapie der chronischen zerebrovaskulären Insuffizienz. Kontrollierte vergleichende Untersuchung zweier zerebraler Antihypoxidotika.